A small molecule directly inhibits the p53 transactivation domain from binding to replication protein A

Jason G. Glanzer, Katie A. Carnes, Patricia Soto, Shengqin Liu, Lawrence J. Parkhurst, Gregory G. Oakley

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Replication protein A (RPA), essential for DNA replication, repair and DNA damage signalling, possesses six ssDNA-binding domains (DBDs), including DBD-F on the N-terminus of the largest subunit, RPA70. This domain functions as a binding site for p53 and other DNA damage and repair proteins that contain amphipathic alpha helical domains. Here, we demonstrate direct binding of both ssDNA and the transactivation domain 2 of p53 (p53TAD2) to DBD-F, as well as DBD-F-directed dsDNA strand separation by RPA, all of which are inhibited by fumaropimaric acid (FPA). FPA binds directly to RPA, resulting in a conformational shift as determined through quenching of intrinsic tryptophan fluorescence in full length RPA. Structural analogues of FPA provide insight on chemical properties that are required for inhibition. Finally, we confirm the inability of RPA possessing R41E and R43E mutations to bind to p53, destabilize dsDNA and quench tryptophan fluorescence by FPA, suggesting that protein binding, DNA modulation and inhibitor binding all occur within the same site on DBD-F. The disruption of p53-RPA interactions by FPA may disturb the regulatory functions of p53 and RPA, thereby inhibiting cellular pathways that control the cell cycle and maintain the integrity of the human genome.

Original languageEnglish
Pages (from-to)2047-2059
Number of pages13
JournalNucleic Acids Research
Volume41
Issue number3
DOIs
StatePublished - Feb 2013

Fingerprint

Replication Protein A
Transcriptional Activation
Tryptophan
DNA Repair
DNA Damage
Fluorescence
DNA-Binding Proteins
Human Genome
Cell Cycle Checkpoints
DNA Replication
Binding Sites
fumaropimaric acid
Mutation
4-(N,N-dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole

All Science Journal Classification (ASJC) codes

  • Genetics

Cite this

A small molecule directly inhibits the p53 transactivation domain from binding to replication protein A. / Glanzer, Jason G.; Carnes, Katie A.; Soto, Patricia; Liu, Shengqin; Parkhurst, Lawrence J.; Oakley, Gregory G.

In: Nucleic Acids Research, Vol. 41, No. 3, 02.2013, p. 2047-2059.

Research output: Contribution to journalArticle

Glanzer, Jason G. ; Carnes, Katie A. ; Soto, Patricia ; Liu, Shengqin ; Parkhurst, Lawrence J. ; Oakley, Gregory G. / A small molecule directly inhibits the p53 transactivation domain from binding to replication protein A. In: Nucleic Acids Research. 2013 ; Vol. 41, No. 3. pp. 2047-2059.
@article{e878f400c931403fbe16586ad8351c41,
title = "A small molecule directly inhibits the p53 transactivation domain from binding to replication protein A",
abstract = "Replication protein A (RPA), essential for DNA replication, repair and DNA damage signalling, possesses six ssDNA-binding domains (DBDs), including DBD-F on the N-terminus of the largest subunit, RPA70. This domain functions as a binding site for p53 and other DNA damage and repair proteins that contain amphipathic alpha helical domains. Here, we demonstrate direct binding of both ssDNA and the transactivation domain 2 of p53 (p53TAD2) to DBD-F, as well as DBD-F-directed dsDNA strand separation by RPA, all of which are inhibited by fumaropimaric acid (FPA). FPA binds directly to RPA, resulting in a conformational shift as determined through quenching of intrinsic tryptophan fluorescence in full length RPA. Structural analogues of FPA provide insight on chemical properties that are required for inhibition. Finally, we confirm the inability of RPA possessing R41E and R43E mutations to bind to p53, destabilize dsDNA and quench tryptophan fluorescence by FPA, suggesting that protein binding, DNA modulation and inhibitor binding all occur within the same site on DBD-F. The disruption of p53-RPA interactions by FPA may disturb the regulatory functions of p53 and RPA, thereby inhibiting cellular pathways that control the cell cycle and maintain the integrity of the human genome.",
author = "Glanzer, {Jason G.} and Carnes, {Katie A.} and Patricia Soto and Shengqin Liu and Parkhurst, {Lawrence J.} and Oakley, {Gregory G.}",
year = "2013",
month = "2",
doi = "10.1093/nar/gks1291",
language = "English",
volume = "41",
pages = "2047--2059",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - A small molecule directly inhibits the p53 transactivation domain from binding to replication protein A

AU - Glanzer, Jason G.

AU - Carnes, Katie A.

AU - Soto, Patricia

AU - Liu, Shengqin

AU - Parkhurst, Lawrence J.

AU - Oakley, Gregory G.

PY - 2013/2

Y1 - 2013/2

N2 - Replication protein A (RPA), essential for DNA replication, repair and DNA damage signalling, possesses six ssDNA-binding domains (DBDs), including DBD-F on the N-terminus of the largest subunit, RPA70. This domain functions as a binding site for p53 and other DNA damage and repair proteins that contain amphipathic alpha helical domains. Here, we demonstrate direct binding of both ssDNA and the transactivation domain 2 of p53 (p53TAD2) to DBD-F, as well as DBD-F-directed dsDNA strand separation by RPA, all of which are inhibited by fumaropimaric acid (FPA). FPA binds directly to RPA, resulting in a conformational shift as determined through quenching of intrinsic tryptophan fluorescence in full length RPA. Structural analogues of FPA provide insight on chemical properties that are required for inhibition. Finally, we confirm the inability of RPA possessing R41E and R43E mutations to bind to p53, destabilize dsDNA and quench tryptophan fluorescence by FPA, suggesting that protein binding, DNA modulation and inhibitor binding all occur within the same site on DBD-F. The disruption of p53-RPA interactions by FPA may disturb the regulatory functions of p53 and RPA, thereby inhibiting cellular pathways that control the cell cycle and maintain the integrity of the human genome.

AB - Replication protein A (RPA), essential for DNA replication, repair and DNA damage signalling, possesses six ssDNA-binding domains (DBDs), including DBD-F on the N-terminus of the largest subunit, RPA70. This domain functions as a binding site for p53 and other DNA damage and repair proteins that contain amphipathic alpha helical domains. Here, we demonstrate direct binding of both ssDNA and the transactivation domain 2 of p53 (p53TAD2) to DBD-F, as well as DBD-F-directed dsDNA strand separation by RPA, all of which are inhibited by fumaropimaric acid (FPA). FPA binds directly to RPA, resulting in a conformational shift as determined through quenching of intrinsic tryptophan fluorescence in full length RPA. Structural analogues of FPA provide insight on chemical properties that are required for inhibition. Finally, we confirm the inability of RPA possessing R41E and R43E mutations to bind to p53, destabilize dsDNA and quench tryptophan fluorescence by FPA, suggesting that protein binding, DNA modulation and inhibitor binding all occur within the same site on DBD-F. The disruption of p53-RPA interactions by FPA may disturb the regulatory functions of p53 and RPA, thereby inhibiting cellular pathways that control the cell cycle and maintain the integrity of the human genome.

UR - http://www.scopus.com/inward/record.url?scp=84873690922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873690922&partnerID=8YFLogxK

U2 - 10.1093/nar/gks1291

DO - 10.1093/nar/gks1291

M3 - Article

VL - 41

SP - 2047

EP - 2059

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 3

ER -